For a long time, sourcing was treated as plumbing. It ran in the background. As long as orders were filled, upstream stakeholders did not give it much thought. The buyer placed the order, the wholesaler filled it, and gaps got handled quietly by whoever had time to chase them down.
That perspective no longer applies. In modern pharmacy operations, sourcing has become one of the key areas where margin is either protected or lost. The pharmacies that recognize this are treating sourcing as a strategic function connected to inventory, purchasing, and compliance. Those who still treat it as a back-office task continue to leak margin in an area almost no one is watching.
Why the stakes moved
Two things changed the equation.
The first is the cost of the products moving through the pipeline. High-cost therapeutics have raised the financial stakes of every sourcing decision. When a stockout on a single high-cost product can cost a pharmacy about $1,500 in lost revenue and emergency sourcing, the choice of how to recover from a supply gap is no longer a clerical detail. It is a margin decision.
The second is the nature of supply disruption itself. Shortages are no longer rare events that resolve in a few weeks. According to ASHP, the number of active drug shortages climbed to 223 in early 2026, and USP’s 2025 Annual Drug Shortages Report found that the average shortage duration reached 5.3 years, up from 4.3 years in 2024 and about two years in 2019. Supply disruptions have become a structural feature of the environment, and they rarely arrive one at a time. When several gaps exist, or when personnel resources are limited, manual sourcing recovery quickly becomes the most expensive line item in the operation. Every gap that is handled by hand introduces delay, burns labor, and risks stepping outside primary contract terms.
The hidden cost of disconnected sourcing
Here is the part that is not visible on most reports. When sourcing is disconnected from the rest of the operation, the cost of a recovery decision does not emerge in one place. It scatters.
A buyer sources around a shortfall from a secondary supplier. That decision impacts inventory, because the on-hand position and the cost basis have shifted. It impacts purchasing, because unmonitored manual recovery puts specific volume commitments and brand-to-generic rebate tiers at risk, threatening the financial viability of the primary wholesaler relationship. It impacts compliance, because the documentation for that decision has to exist and be discoverable later. And it impacts the relationship with the primary wholesaler, because a silently resolved fulfillment gap is often perceived upstream as a routine decision to purchase elsewhere.
When sourcing, inventory, purchasing, and compliance live in four separate systems, no single view captures the full cost of the sourcing decision. The pharmacy absorbs the complexity without the tools to manage it, and the margin erosion happens one quiet decision at a time.
What connected sourcing looks like
The alternative is to incorporate sourcing into one operational view rather than address it as a separate task. In practice, that changes the recovery decision in a few specific ways.
The first change is in how a supply gap gets resolved. Automated omit management handles that recovery in a defined sequence. When a primary wholesaler cannot fill an item, the system confirms the primary is unable to fulfill before triggering secondary sourcing. It then routes the omit to a secondary supplier within price guardrails controlled by the pharmacy, and documents every transaction to preserve the audit trail. Primary contract performance is maximized first; secondary sourcing is deployed only when it is the right answer, not the convenient one. The decision that once depended on the person who noticed the gap and had the bandwidth to address it now follows a standardized approach established by the pharmacy.
Because sourcing resides in the same platform as inventory, purchasing, and compliance, the downstream effects are captured without extra work. Inventory positions are updated automatically, compliance documentation is captured as part of the workflow, and purchasing records accurately reflect both the action taken and the rationale behind it, eliminating the need for any post hoc reconstruction.
The signal that strengthens supply chain visibility
There is a second, less obvious benefit that extends beyond the pharmacy and supports broader supply chain performance.
When a pharmacy sources around a shortfall without a consistent way to capture and communicate that activity, an actual availability issue and a routine purchasing decision can appear the same in downstream data. That lack of visibility can make it more difficult for supply chain partners to understand true demand patterns and identify recurring fulfillment challenges.
Pharmacies operating on a single intelligent platform generate more complete transaction data and more consistent ordering signals. When availability gaps and the alternate sourcing paths taken to address them remain documented and connected, the underlying demand signal is preserved. Supply chain partners gain better visibility into unmet demand rather than losing sight of it entirely.
With a clearer view of both demand and supply constraints, stakeholders across the supply chain can identify recurring availability issues earlier, improve planning decisions, and reduce the operational impact of shortages. Effective sourcing practices do more than protect pharmacy operations and margins. They help create a more transparent, informed, and resilient supply chain for everyone involved.
From cost center to margin lever
The shift here is a shift in how sourcing is understood. When it sits in the background, disconnected from inventory, purchasing, and compliance, it behaves like a cost center and a source of quiet risk. When it runs as part of one platform, it becomes a lever the pharmacy can pull to protect margin, hold contract compliance, preserve the supplier relationship, and actively protect patient care continuity at scale. The pharmacies pulling ahead have stopped asking whether an order got filled and started asking how and at what cost. This is not a back-office question anymore. It is an operations question, and the answer lives in whether sourcing is connected to the rest of the platform or stranded on its own.
